In addition to drugs for widespread illnesses, there is a great need for medications to treat special medical conditions. RIEMSER specializes in these pharmaceuticals, for which there is a high unmet medical need.
Within the framework of its clearly defined corporate strategy, RIEMSER has been focusing on further expanding its global reach as well as its product portfolio in selected therapeutic areas since 2009. These areas primarily include oncology and rheumatology, infectiology, dermatology and cardiovascular diseases. RIEMSER is an ideal partner for other pharmaceutical companies when it comes to tapping into new markets for specialty pharmaceuticals, extending product life cycles and increasing profitability. The company is constantly developing its marketing and life cycle expertise.